Difelikefalin
Overview
Difelikefalin is a protein active pharmaceutical ingredient (ChEMBL CHEMBL3989915).
API suppliers (1)
Suppliers of Difelikefalin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- Hybio Pharmaceutical Co., Ltd.China1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Difelikefalin expires 12 Nov 2032 and exclusivity 23 Aug 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 4-amino-1-[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid
- Canonical SMILES
- CC(C)C[C@H](C(=O)N[C@H](CCCCN)C(=O)N1CCC(CC1)(C(=O)O)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC3=CC=CC=C3)N
- InChIKey
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N
Do you supply Difelikefalin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.